Loss of taste-induced hypertension - Caveat for taste modulation as a therapeutic option in obesity

Eating and Weight Disorders

Volumn 12, Issue 1, 2007, Pages

  Czupryniak, Leszek ^a   Loba, J ^a  

^a Barlicki University Hospital No 1 ^*  (Poland)

Author keywords

Dysgeusia; Hypertension; Obesity; Salt intake; Stroke

Indexed keywords

ADULT; ARTICLE; BODY WEIGHT; CASE REPORT; DYSGEUSIA; FEMALE; GLOSSOPHARYNGEAL NERVE; HUMAN; HYPERTENSION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; SALT INTAKE; STROKE; TASTE; TASTE DISORDER; WEIGHT REDUCTION; CEREBROVASCULAR ACCIDENT; GLOSSOPHARYNGEAL NERVE DISEASE; MIDDLE AGED; SODIUM INTAKE;

CEREBROVASCULAR ACCIDENT; DIABETES MELLITUS, TYPE 2; FEMALE; GLOSSOPHARYNGEAL NERVE DISEASES; HUMANS; HYPERTENSION; MIDDLE AGED; OBESITY; SODIUM, DIETARY; TASTE DISORDERS;

EID: 33947721062     PISSN: 11244909     EISSN: 15901262     Source Type: Journal    
DOI: 10.1007/BF03327775     Document Type: Article

References (22)

1. Padwal R., Li S., Lau D.: Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst. Rev., 4, CD004094, 2003.
2. Czupryniak L., Drzewoski J.: The role of pharmacotherapy in the treatment of obesity in adults. Pol. Merkuriusz Lek., 9, 741-745, 2000.
3. Freudenheim M.: A boom in surgery to shrink the stomach. New York Times, Aug 30-31, 2003.
4. Strzelczyk J., Czupryniak L., Loba J., Wasiak J.: The use of polypropylene mesh in midline incision closure following gastric by-pass surgery reduces the risk of postoperative hernia. Langenbeck's Arch. Surg., 387, 294-297, 2002.
5. Strzelczyk J., Czupryniak L., Pawlowski M., Szymanski D., Nowicki M., Gaszynski T., Wozniak-Sosnowska U., Wasiak J., Loba J.: Early results of surgical treatment of obesity. Diabetol. Pol., 10, 246-253, 2003.
6. Mitka M.: Surgery for obesity: demand soars amid scientific, ethical questions. JAMA, 289, 1761-1762, 2003.
7. Poothullil J.M.: Maintenance of weight loss using taste and smell sensations. J Women's Health, 8, 109-113, 1999.
8. Woschnagg H., Stollberger C., Finsterer J.: Loss of taste is loss of weight. Lancet, 359, 891, 2002.
9. Henkin R.I.: Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf., 11, 318-377, 1994.
10. Zeller J.A., Machetanz J., Kessler C.: Ageusia as an adverse effect of phenytoin treatment. Lancet, 351, 1101, 1998.
11. Golka K., Roth E., Huber J., Schmitt K.: Reversible ageusia as an effect of clopidogrel treatment. Lancet, 355, 465-466, 2000.
12. Smith F.R., Dell R.B., Henkin R.I.: Disordered gustatory acuity in liver disease. Gastroenterology, 70, 568-571, 1976.
13. Chapman-Novakofski K., Brewer M.S., Riskowski J., Burkowski C., Winter L.: Alterations in taste thresholds in men with chronic obstructive pulmonary disease. J. Am. Diet. Assoc., 99, 1536-1541, 1999.
14. Rousseaux M., Muller P., Gahide I., Mottin Y., Romon M.: Disorders of smell, taste, and food intake in a patient with a dorsomedial thalamic infarct. Stroke, 27, 2328-2330, 1996.
15. Onoda K., Ikeda M.: Gustatory disturbance due to cerebrovascular disorder. Laryngoscope, 109, 123-128, 1999.
16. Kim J.S., Choi S.: Altered food preference after cortical infarction: Korean style. Cerebrovasc. Dis., 13, 187-191, 2002.
17. Henkin R.I.: Evaluation and treatment of human olfactory dysfunction. In: English G.M. (Ed.), Otolaryngology. vol. 2. Philadelphia, Lippincott, 1993, pp. 1-86.
18. Henkin R.I.: Smell, taste, head trauma, and hypopituitarism. J. Clin. Endocrinol. Metab., 86, 1427-1428, 2001.
19. Warlow C., Sudlow C., Dennis M., Wardlaw J., Sandercock P.: Stroke. Lancet, 362, 1211-1224, 2003.
20. Law M.R.: Epidemiological evidence on salt and blood pressure. Am. J. Hypertens., 10 (suppl.), 42S-45S, 1997.
21. World Health Organisation. 1999 World Health Organisation - International Society of Hypertension Guidelines for the Management of Hypertension. J. Hypertens., 17, 151-183, 1999.
22. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38. BMJ, 317, 703-713, 1998.